Skip to main content

Newsmakers

Jeffrey H. Cooper : Appointed to Board of ProNAi Therapeutics

Alumnus Jeffrey H. Cooper MBA ‘80 has been appointed to the Board of Directors for ProNAi Therapeutics.

Alumnus Jeffrey H. Cooper MBA ‘80 has been appointed to the Board of Directors for ProNAi Therapeutics.

"Mr. Cooper [has] extensive and relevant experiences in guiding the financial functions of public healthcare companies. [He] brings a commitment to the important role of sound financial management in governing an emerging public company," said Donald Parfet, Chairman of the Board of Directors of ProNAi, in a recent press release.

ProNAi Therapeutics, Inc. is a clinical-stage oncology company advancing novel therapeutics for patients with cancer and hematological diseases.

Find the full press release here.

LSB Newsmakers, LSB Alumni,